(Q43273928)

18 November 2017

title

Ranolazine, an antianginal agent, markedly reduces ventricular arrhythmias induced by ischemia and ischemia-reperfusion (English)

1 reference

18 November 2017

Arvinder K Dhalla

1

1 reference

18 November 2017

Wei-Qun Wang

2

1 reference

18 November 2017

Joan Dow

3

1 reference

18 November 2017

John C Shryock

4

1 reference

18 November 2017

Luiz Belardinelli

5

1 reference

18 November 2017

Anil Bhandari

6

1 reference

18 November 2017

Robert A Kloner

7

1 reference

18 November 2017

publication date

18 September 2009

1 reference

American Journal of Physiology Heart and Circulatory Physiology

18 November 2017

published in

1 reference

18 November 2017

volume

297

1 reference

18 November 2017

issue

5

1 reference

18 November 2017

page(s)

H1923-9

1 reference

The role of sodium channel current in modulating transmural dispersion of repolarization and arrhythmogenesis.

18 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Ranolazine for the treatment of chronic angina and potential use in other cardiovascular conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Models for the study of arrhythmias in myocardial ischaemia and infarction: the use of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Protection against myocardial ischemic/reperfusion injury by inhibitors of two separate pathways of Na+ entry.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Improved left ventricular function and reduced necrosis after myocardial ischemia/reperfusion in rabbits treated with ranolazine, an inhibitor of the late sodium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Ranolazine, an inhibitor of the late sodium channel current, reduces postischemic myocardial dysfunction in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

The antianginal agent, ranolazine, reduces myocardial infarct size but does not alter anatomic no-reflow or regional myocardial blood flow in ischemia/reperfusion in the rabbit

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Late sodium current inhibition as a new cardioprotective approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Postconditioning markedly attenuates ventricular arrhythmias after ischemia-reperfusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Effect of hydrogen peroxide on persistent sodium current in guinea pig ventricular myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Effects of ranolazine on recurrent cardiovascular events in patients with non-ST-elevation acute coronary syndromes: the MERLIN-TIMI 36 randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Late sodium current in the pathophysiology of cardiovascular disease: consequences of sodium-calcium overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

The dependence of calcium efflux from cardiac muscle on temperature and external ion composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Comparative efficacy of ranolazine versus atenolol for chronic angina pectoris

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Ranolazine: ion-channel-blocking actions and in vivo electrophysiological effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

An increase of late sodium current induces delayed afterdepolarizations and sustained triggered activity in atrial myocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Blocking late sodium current reduces hydrogen peroxide-induced arrhythmogenic activity and contractile dysfunction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Na(+)-Ca(2+) exchanger overexpression predisposes to reactive oxygen species-induced injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Antiarrhythmic effects of ranolazine in a guinea pig in vitro model of long-QT syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

Pathophysiology and pharmacology of the cardiac "late sodium current.".

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPHEART.00173.2009

10.1152/AJPHEART.00173.2009

21 January 2018

Identifiers

DOI

1 reference

18 November 2017

1 reference